Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Aurobindo Pharma strengthens its domestic formulations market with a ₹325 crore acquisition of Khandelwal Laboratories' non-oncology business. The deal includes 23 established brands and boosts presence in pain & anti-infective segments. Read more.
A Bengaluru software engineer was arrested for allegedly manufacturing synthetic drugs like MDMA in a makeshift home laboratory. Police seized drugs worth lakhs and equipment. Read the shocking details.
Drugs Control Administration officials raided an unlicensed clinic in Karimnagar, seizing illegal steroids and antibiotics. The crackdown highlights the public health risks of unauthorized drug sales. Read more.
Explore the social and economic impact of GLP-1 drugs like Ozempic & Mounjaro in India. A ₹1,000 crore market is poised for massive growth. Share your thoughts.
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
The Supreme Court has agreed to hear SAD leader Bikram Singh Majithia's plea for bail in a drugs case. The hearing is scheduled for July 15. Read the latest legal developments.
Karnataka Assembly passes the Drugs and Cosmetics (Amendment) Bill, 2024, enhancing penalties for spurious drug manufacturers and regulating online pharmacy sales. Learn the key changes.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
Delhi High Court permits Dr Reddy's to export generic semaglutide, a major win for Indian drugmakers eyeing the booming anti-obesity market. Read the full analysis.
WWE Hall of Famer Ric Flair discloses Hulk Hogan turned to street drugs after multiple surgeries left him in unbearable pain. Read the shocking details.
India's drug regulator CDSCO refuses to waive local trials for lenacapavir, blocking access to revolutionary HIV prevention for 25 lakh Indians. Learn why this happens despite drug being manufactured in India.
RGIA Hyderabad becomes frontline in India's fight against hydroponic cannabis smuggling from Southeast Asia. Discover how smugglers are targeting air travelers.
Himachal Pradesh schools partner with police in innovative sports initiative to combat drug abuse among youth. Learn how education and sports create positive alternatives.
Rajesh Bakshi and accomplice Jon-Paul Clark sentenced for attempting to smuggle 40kg heroin into UK. NCA investigation reveals international drug trafficking network.
Learn how improper storage of antibiotics, insulin, and heart drugs can make them less effective before expiry. Essential guide for Indian households to protect medicine potency.
Kavundampalayam police arrested R Peter, 27, for possessing 171g methamphetamine for sale. The Kerala native sourced drugs from Bengaluru. Read the full investigation details.
Millions on GLP-1 drugs are rethinking Thanksgiving. Some skip doses for appetite, others embrace smaller portions. Discover the new holiday era.
Americans on GLP-1 medications are skipping doses and adjusting menus for Thanksgiving feasts. Discover how these powerful drugs are reshaping holiday traditions and eating habits.
Social media star Orry faced fan frenzy while appearing before Mumbai Police in the ₹252 crore drug case. Watch the dramatic scenes unfold as he arrives for questioning.
Bollywood socialite Orry was questioned by Mumbai Police in a drugs case linked to alleged rave parties for celebrities. Get the latest updates on the investigation.
Shaily Engineering and Gland Pharma positioned to benefit from India's semaglutide gold rush as patent expiry opens market for generic weight-loss drugs. Discover how these companies are preparing.